arrow_back Back to App

Newborn CMV Screening: Standards, Support, and Research

This act mandates congenital Cytomegalovirus (CMV) screening for newborns in hospitals. This means your baby may be tested for this infection, allowing for early detection and potential treatment to reduce the risk of serious health issues. The act also provides financial support for states to implement these screenings and educate the public.
Key points
Mandatory screening for congenital Cytomegalovirus (CMV) for newborns up to 21 days old.
States can develop their own screening standards; if not, an advisory committee will establish them.
Grants will be available for hospitals to administer tests and for states for data collection systems and public education.
Funding for research into new CMV detection, prevention, and treatment methods through the National Institutes of Health.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_S_2842
Sponsor: Sen. Blumenthal, Richard [D-CT]
Process start date: 2025-09-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Stop CMV Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_S_2842.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-09-17.

What are the main provisions?

Key points include:

  • Mandatory screening for congenital Cytomegalovirus (CMV) for newborns up to 21 days old.
  • States can develop their own screening standards; if not, an advisory committee will establish them.
  • Grants will be available for hospitals to administer tests and for states for data collection systems and public education.
  • Funding for research into new CMV detection, prevention, and treatment methods through the National Institutes of Health.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Blumenthal, Richard [D-CT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health Family